🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Virginia › Richmond

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Richmond, VA keessatti

Qorannoo 5 Kansaar Onnee Triple-Negative f Richmond fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Namoota walitti qabaa jiraSadarkaa 3
  • Virginia Cancer Institute ( Site 0034), Richmond
  • Bon Secours Memorial Regional Medical Center-Oncology Research Department ( Site 0020), Midlothian · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Namoota walitti qabaa jiraSadarkaa 3
  • Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • VCU Massey Comprehensive Cancer Center, Richmond
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT03606967

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Namoota walitti qabaa jiraSadarkaa 3
  • Bon Secours Cancer Institute at St. Francis, Midlothian · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05633654

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Namoota walitti qabaa jiraSadarkaa 2/3
  • Bon Secours St. Francis Medical Center, Midlothian · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06926868

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo Richmond keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.